Pharmena S.A. (WSE:PHR)
 3.350
 0.00 (0.00%)
  Nov 3, 2025, 2:18 PM CET
Pharmena Revenue
Pharmena had revenue of 386.00K PLN in the quarter ending June 30, 2025, with 160.81% growth. This brings the company's revenue in the last twelve months to 889.00K, up 205.50% year-over-year. In the year 2024, Pharmena had annual revenue of 268.00K, down -10.37%.
Revenue (ttm) 
 889.00K
Revenue Growth 
 +205.50%
P/S Ratio 
 42.22
Revenue / Employee 
 127.00K
Employees 
 7
Market Cap 
37.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% | 
| Dec 31, 2023 | 299.00K | - | - | 
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% | 
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% | 
| Dec 31, 2020 | 9.93M | -1.17M | -10.51% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| NEUCA | 13.04B | 
| Diagnostyka | 2.17B | 
| Centrum Medyczne ENEL-MED | 789.78M | 
| Synektik Spólka Akcyjna | 623.20M | 
| Mercator Medical | 579.83M | 
| Voxel | 560.38M | 
| Selvita | 373.90M | 
| Celon Pharma | 206.22M |